New synthetic cannabinoid intoxications in emergency department (It's grass, Its no sin)

Doğan, Halil; Özüçelik, Doğaç Niyazi; Açıksarı, Kurtuluş; Avcı, Akkan; Yazıcıoğlu, Mustafa Ömer; Çelikmen, Mustafa Ferudun; Karşıdağ, Çağatay; Erkıran, Murat; Aksoy, Umut Mert

doi:10.5455/apd.184669

Cited by 5 publications

(6 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Doğan et al (3) reported that 74.2% of patients, who had a higher rate of liver and renal dysfunction, had a history of substance use, although the difference did not reach statistical significance (2). On the other hand, 90.6% of our patients had been using Bonsai for six months.…”

Section: Discussioncontrasting

confidence: 52%

“…Published reports suggest that although synthetic cannabinoids are generally used in cigarette form, they can be inhaled in vaporized form or taken orally or rectally (2,3,18). In our study, cigarette form was the most common form (94.6%), but the route of use was not significantly correlated to intoxication.…”

Section: Discussioncontrasting

confidence: 48%

“…Barratt et al (16) reported that 68% of patients experienced at least one side effect, the most common of which was impaired motor coordination (39%). Doğan et al (3) stated that dizziness and agitation were the most common symptoms. Zimmermann et al (21) stressed that patients regularly using Bonsai may suffer from signs and symptoms of abstinence syndrome, which include shivering, headache, nightmares, craving, hypertension, and tachycardia.…”

Section: Discussionmentioning

confidence: 99%

“…Having the central effects of marijuana, these substances have been introduced as "harmless", "legal marijuana", and as "a designed drug" (2). Being readily accessible and cheap, as well as lacking the narcotic substance status, these substances have gained a rapidly increasing popularity, particularly among adolescents and young adults (3,4).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Investigation of the Clinical Course and Outcomes of Bonsai Use

Kavak¹,

Çavuş²,

Kavak³

et al. 2019

Eurasian J Emerg Med

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 52%

Section: Discussioncontrasting

confidence: 48%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Investigation of the Clinical Course and Outcomes of Bonsai Use

Kavak¹,

Çavuş²,

Kavak³

et al. 2019

Eurasian J Emerg Med

View full text Add to dashboard Cite

show abstract

“…There are few studies on the use of SC in terms of psychiatry in Turkey (10,11,12). In this study, we aimed to investigate socio-demographic and clinical characteristics associated with SC use and the negative consequences caused by the use of SC in an example of outpatient population.…”

Section: Introductionmentioning

confidence: 99%

Socio-demographic and Clinical Features of Young Adult Males Using Synthetic Cannabinoid (English)

Öznur¹,

Öznur²,

Bolu³

et al. 2018

J Clin Psy

View full text Add to dashboard Cite

SUMMARYObject: Synthetic Cannabinoid (SC) use is becoming more widespread throughout the world. Studies that revealed user profiles indicate that the drug is especially popular among young men. Knowledge on sociodemographic, clinical characteristics and motivation for SC users in our country is limited. On the other hand, in spite of the increase of information known about symptoms of acute intoxication of SC use, physical and psychiatric consequences and loss of function due to longterm use of SC is limited. In this study, we aimed to investigate socio-demographic and clinical characteristics associated with SC use and the negative consequences caused by the use of SC. Methods: 166 male patients who admitted to the psychiatric outpatient clinic due to SC use disorder between November 2014 to April 2015 were enrolled in the study. Demographic data of patients, substance use characteristics, familial substance use, reasons for substance use, medical history, the problems related to drug use was questioned. Results: The age of onset for SC use was found to be 17.25 ± 2.30. SC using duration was 3.79 ± 2.15 years. The most common agents accompanying SC use were smoking (95.8%) and cannabis (88.6%). It was determined that 62.7% developed suicidal ideas due to SC use. Among psychiatric side effects, most common were euphoria, hallucinations, skepticism and suicidal ideation. About 1/3 of cases were found to live loss of business and legal issues depending on long-term SC use. 76.5% of the patients' consumed SC through inhalation and 22.9 % orally. It was determined that oral users began SC use at an earlier age than users via inhalation. Discussion: Despite the physical, mental, occupational, social and legal problems caused by the use of SC, it has become an important public health problem, especially among young men. Effective intervention programs for the use of outbreaking SCs need to be developed.

show abstract

What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review

Jouanjus

Raymond

Lapeyre‐Mestre

et al. 2017

Curr Atheroscler Rep

114

View full text Add to dashboard Cite

The World Health Organization (WHO) emphasizes that cannabis use represents a risky behavior as it may lead to many adverse effects, and in particular, cardiovascular effects. A systematic review of articles published between January 1, 2011 and May 31, 2016 was performed in agreement with the PRISMA statement. Articles presenting data on humans exposed to cannabis-based products and suffering from any cardiovascular condition were eligible for inclusion. The inclusion process was based on a search algorithm and performed in a blinded standardized manner. Overall, 826 articles were found in the literature search, 115 of which remained after performing the inclusion procedure. These were 81 case reports, 29 observational studies, 3 clinical trials, and 2 experimental studies. A total of 116 individuals was the subject of case reports. The mean age was 31 years (95%CI = 29-34), and patients were more frequently men (81.9%) than women (18.1%). They mainly suffered from ischemic strokes or myocardial infarctions. Data provided by the 29 included observational studies evidenced an association between exposure to cannabis-based products and cardiovascular disease. Currently, this evidence is stronger for ischemic strokes than for any other cardiovascular diseases. While the data are limited, there is some suggestion that cannabis use may have negative cardiovascular consequences, particularly at large doses.

show abstract

New synthetic cannabinoid intoxications in emergency department (It's grass, Its no sin)

Cited by 5 publications

References 25 publications

Investigation of the Clinical Course and Outcomes of Bonsai Use

Investigation of the Clinical Course and Outcomes of Bonsai Use

Socio-demographic and Clinical Features of Young Adult Males Using Synthetic Cannabinoid (English)

What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review

Contact Info

Product

Resources

About